Cancer Incidence and Mortality among Non-Hispanic Blacks, New York County (Manhattan), 2015-2019
Source: New York State Cancer Registry
| Site of Cancer | Incidence | Mortality | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 1331.4 | 512.6 | 500.1-525.3 | 634.6 | 597.6 | 576.4-619.4 | 696.8 | 466.7 | 450.9-483.0 | 487.0 | 185.2 | 177.8-192.9 | 220.6 | 225.0 | 211.6-239.1 | 266.4 | 165.1 | 156.2-174.5 |
| Oral cavity and pharynx | 25.8 | 10.0 | 8.3-11.9 | 15.6 | 14.6 | 11.5-18.4 | 10.2 | 6.9 | 5.1-9.2 | 7.8 | 2.9 | 2.1-4.0 | 4.4 | 4.2 | 2.6-6.5 | 3.4 | 2.1 | 1.2-3.5 |
| Esophagus | 10.6 | 3.9 | 2.9-5.2 | 5.8 | 5.5 | 3.6-8.0 | 4.8 | 3.0 | 1.9-4.5 | 7.4 | 2.8 | 2.0-3.9 | 4.0 | 4.3 | 2.6-6.8 | 3.4 | 2.1 | 1.2-3.4 |
| Stomach | 25.8 | 10.0 | 8.3-11.9 | 14.6 | 14.2 | 11.1-18.0 | 11.2 | 7.2 | 5.4-9.5 | 12.2 | 4.5 | 3.5-5.9 | 6.8 | 6.4 | 4.4-9.1 | 5.4 | 3.1 | 2.1-4.7 |
| Colorectal | 108.6 | 42.1 | 38.6-45.9 | 57.2 | 56.4 | 49.8-63.5 | 51.4 | 33.3 | 29.3-37.9 | 46.4 | 17.7 | 15.5-20.2 | 23.2 | 24.3 | 20.0-29.3 | 23.2 | 13.7 | 11.3-16.5 |
| Colon excluding rectum | 77.6 | 29.9 | 26.9-33.1 | 39.6 | 39.4 | 34.0-45.5 | 38.0 | 24.2 | 20.8-28.0 | 36.0 | 13.8 | 11.8-16.0 | 16.6 | 17.3 | 13.7-21.6 | 19.4 | 11.5 | 9.3-14.1 |
| Rectum & rectosigmoid | 31.0 | 12.2 | 10.3-14.4 | 17.6 | 16.9 | 13.5-21.0 | 13.4 | 9.2 | 7.1-11.8 | 10.4 | 3.9 | 2.9-5.2 | 6.6 | 7.0 | 4.8-9.9 | 3.8 | 2.2 | 1.3-3.6 |
| Liver / intrahepatic bile duct | 42.6 | 15.5 | 13.5-17.8 | 30.4 | 27.6 | 23.3-32.5 | 12.2 | 7.5 | 5.7-9.7 | 26.8 | 9.9 | 8.3-11.8 | 17.6 | 17.1 | 13.6-21.2 | 9.2 | 5.6 | 4.1-7.6 |
| Pancreas | 50.8 | 19.3 | 17.0-21.9 | 23.2 | 22.7 | 18.6-27.3 | 27.6 | 17.0 | 14.2-20.2 | 41.4 | 15.6 | 13.5-17.9 | 16.2 | 16.1 | 12.7-20.1 | 25.2 | 15.2 | 12.7-18.2 |
| Larynx | 10.4 | 3.8 | 2.9-5.1 | 7.8 | 7.1 | 5.0-9.9 | 2.6 | 1.7 | 0.9-3.1 | 4.4 | 1.6 | 1.0-2.4 | 3.2 | 3.0 | 1.7-4.9 | 1.2 | 0.7 | 0.3-1.7 |
| Lung and bronchus | 167.4 | 63.1 | 58.9-67.6 | 75.2 | 72.6 | 65.3-80.6 | 92.2 | 57.1 | 52.0-62.7 | 101.4 | 38.1 | 34.9-41.7 | 49.2 | 48.7 | 42.7-55.4 | 52.2 | 31.9 | 28.1-36.1 |
| Melanoma of the skin | 3.4 | 1.2 | 0.7-2.0 | 1.0 | 0.9 | 0.3-2.3 | 2.4 | 1.6 | 0.8-2.9 | 0.6 | 0.2 | 0.0-0.7 | 0.0 | 0.0 | 0.0-0.8 | 0.6 | 0.3 | 0.1-1.2 |
| Female breast | 205.2 | 144.1 | 135.2-153.6 | 47.2 | 30.7 | 26.7-35.1 | ||||||||||||
| Cervix uteri | 16.2 | 11.5 | 9.1-14.4 | 5.8 | 4.0 | 2.7-5.9 | ||||||||||||
| Corpus uterus and NOS | 59.2 | 38.2 | 33.9-43.0 | 18.4 | 11.2 | 9.0-13.8 | ||||||||||||
| Ovary | 14.4 | 10.0 | 7.8-12.7 | 11.0 | 6.8 | 5.1-9.0 | ||||||||||||
| Prostate | 221.4 | 199.5 | 187.6-212.0 | 35.4 | 38.8 | 33.2-45.0 | ||||||||||||
| Testis | 4.2 | 3.7 | 2.2-5.8 | 0.2 | 0.2 | 0.0-1.3 | ||||||||||||
| Urinary bladder (incl. in situ) | 36.0 | 13.8 | 11.8-16.0 | 22.0 | 22.8 | 18.7-27.6 | 14.0 | 8.7 | 6.8-11.2 | 12.4 | 4.6 | 3.5-6.0 | 7.2 | 8.0 | 5.6-11.1 | 5.2 | 2.8 | 1.8-4.3 |
| Kidney and renal pelvis | 48.8 | 18.8 | 16.5-21.4 | 29.0 | 26.1 | 21.9-30.9 | 19.8 | 13.2 | 10.7-16.2 | 7.4 | 2.8 | 2.0-3.9 | 3.2 | 3.2 | 1.8-5.3 | 4.2 | 2.5 | 1.5-3.9 |
| Brain and other central nervous system | 9.4 | 3.9 | 2.9-5.3 | 4.6 | 4.6 | 2.8-6.9 | 4.8 | 3.4 | 2.1-5.2 | 5.4 | 2.1 | 1.4-3.1 | 3.2 | 3.0 | 1.7-4.9 | 2.2 | 1.4 | 0.7-2.7 |
| Thyroid | 24.2 | 10.0 | 8.3-12.0 | 4.2 | 3.5 | 2.2-5.5 | 20.0 | 15.8 | 12.7-19.3 | 0.8 | 0.3 | 0.1-0.9 | 0.6 | 0.6 | 0.1-1.8 | 0.2 | 0.1 | 0.0-0.9 |
| Hodgkin lymphoma | 9.4 | 4.0 | 2.9-5.4 | 4.8 | 4.7 | 2.9-7.0 | 4.6 | 3.6 | 2.2-5.4 | 0.4 | 0.2 | 0.0-0.6 | 0.2 | 0.2 | 0.0-1.1 | 0.2 | 0.1 | 0.0-0.9 |
| Non-Hodgkin lymphomas | 51.4 | 20.8 | 18.2-23.6 | 25.4 | 24.2 | 20.1-29.0 | 26.0 | 18.2 | 15.1-21.8 | 10.8 | 4.4 | 3.3-5.8 | 5.4 | 5.7 | 3.7-8.3 | 5.4 | 3.5 | 2.3-5.3 |
| Myeloma | 36.8 | 14.3 | 12.3-16.6 | 15.8 | 15.5 | 12.2-19.5 | 21.0 | 13.5 | 10.9-16.4 | 12.4 | 4.7 | 3.6-6.1 | 5.4 | 5.6 | 3.6-8.2 | 7.0 | 4.2 | 2.9-5.9 |
| Leukemias | 28.4 | 11.4 | 9.6-13.5 | 13.6 | 13.6 | 10.5-17.4 | 14.8 | 10.0 | 7.7-12.8 | 13.8 | 5.6 | 4.3-7.2 | 6.0 | 6.5 | 4.3-9.3 | 7.8 | 5.2 | 3.7-7.3 |
Notes
- Incidence data are provisional, November 2021.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.
